nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Temozolomide—malignant glioma	0.332	0.522	CiPCiCtD
Melphalan—peripheral nervous system neoplasm—malignant glioma	0.313	1	CtDrD
Melphalan—Alkylating Activity—Carmustine—malignant glioma	0.304	0.478	CiPCiCtD
Melphalan—Venoocclusive disease—Carmustine—malignant glioma	0.00337	0.0883	CcSEcCtD
Melphalan—Wound—Carmustine—malignant glioma	0.00268	0.0701	CcSEcCtD
Melphalan—Pulmonary toxicity—Carmustine—malignant glioma	0.00171	0.0448	CcSEcCtD
Melphalan—Infertility—Carmustine—malignant glioma	0.00149	0.039	CcSEcCtD
Melphalan—Infertility—Temozolomide—malignant glioma	0.00144	0.0377	CcSEcCtD
Melphalan—Acute leukaemia—Carmustine—malignant glioma	0.00136	0.0356	CcSEcCtD
Melphalan—SLC7A5—Basigin interactions—ATP1B2—malignant glioma	0.00132	0.143	CbGpPWpGaD
Melphalan—Acute leukaemia—Temozolomide—malignant glioma	0.00131	0.0344	CcSEcCtD
Melphalan—Chlorambucil—GSTP1—malignant glioma	0.00118	0.657	CrCbGaD
Melphalan—Skin necrosis—Carmustine—malignant glioma	0.00111	0.0291	CcSEcCtD
Melphalan—Impaired healing—Carmustine—malignant glioma	0.000899	0.0235	CcSEcCtD
Melphalan—Pulmonary fibrosis—Carmustine—malignant glioma	0.000884	0.0231	CcSEcCtD
Melphalan—Pulmonary fibrosis—Temozolomide—malignant glioma	0.000854	0.0224	CcSEcCtD
Melphalan—Myelosuppression—Carmustine—malignant glioma	0.000829	0.0217	CcSEcCtD
Melphalan—Myelosuppression—Temozolomide—malignant glioma	0.000801	0.021	CcSEcCtD
Melphalan—Interstitial pneumonia—Temozolomide—malignant glioma	0.000777	0.0203	CcSEcCtD
Melphalan—Febrile neutropenia—Carmustine—malignant glioma	0.000646	0.0169	CcSEcCtD
Melphalan—Transaminases increased—Carmustine—malignant glioma	0.000639	0.0167	CcSEcCtD
Melphalan—Febrile neutropenia—Temozolomide—malignant glioma	0.000624	0.0163	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000596	0.0646	CbGpPWpGaD
Melphalan—Digestion impaired—Temozolomide—malignant glioma	0.000562	0.0147	CcSEcCtD
Melphalan—Interstitial lung disease—Carmustine—malignant glioma	0.000549	0.0144	CcSEcCtD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SYP—malignant glioma	0.000532	0.0577	CbGpPWpGaD
Melphalan—Interstitial lung disease—Temozolomide—malignant glioma	0.000531	0.0139	CcSEcCtD
Melphalan—Extravasation—Carmustine—malignant glioma	0.000446	0.0117	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ATP1B2—malignant glioma	0.000438	0.0475	CbGpPWpGaD
Melphalan—Amenorrhoea—Temozolomide—malignant glioma	0.000428	0.0112	CcSEcCtD
Melphalan—Injection site reaction—Carmustine—malignant glioma	0.000386	0.0101	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000374	0.0406	CbGpPWpGaD
Melphalan—Skin exfoliation—Carmustine—malignant glioma	0.000371	0.00971	CcSEcCtD
Melphalan—Neuropathy—Carmustine—malignant glioma	0.000365	0.00955	CcSEcCtD
Melphalan—SLC7A5—Basigin interactions—CAV1—malignant glioma	0.000363	0.0394	CbGpPWpGaD
Melphalan—Skin exfoliation—Temozolomide—malignant glioma	0.000359	0.00939	CcSEcCtD
Melphalan—Neuropathy—Temozolomide—malignant glioma	0.000353	0.00923	CcSEcCtD
Melphalan—Neoplasm—Carmustine—malignant glioma	0.000351	0.0092	CcSEcCtD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.000351	0.0381	CbGpPWpGaD
Melphalan—Neoplasm—Temozolomide—malignant glioma	0.00034	0.00889	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ANGPT2—malignant glioma	0.000323	0.035	CbGpPWpGaD
Melphalan—Hyponatraemia—Carmustine—malignant glioma	0.000283	0.00741	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000275	0.0298	CbGpPWpGaD
Melphalan—Liver function test abnormal—Carmustine—malignant glioma	0.000261	0.00682	CcSEcCtD
Melphalan—Pancytopenia—Carmustine—malignant glioma	0.000232	0.00606	CcSEcCtD
Melphalan—Neutropenia—Carmustine—malignant glioma	0.000228	0.00597	CcSEcCtD
Melphalan—Pancytopenia—Temozolomide—malignant glioma	0.000224	0.00586	CcSEcCtD
Melphalan—Neutropenia—Temozolomide—malignant glioma	0.00022	0.00577	CcSEcCtD
Melphalan—Neuropathy peripheral—Carmustine—malignant glioma	0.000213	0.00558	CcSEcCtD
Melphalan—Stomatitis—Carmustine—malignant glioma	0.000212	0.00555	CcSEcCtD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.000207	0.0224	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Temozolomide—malignant glioma	0.000206	0.00539	CcSEcCtD
Melphalan—Stomatitis—Temozolomide—malignant glioma	0.000205	0.00536	CcSEcCtD
Melphalan—Ibuprofen—BCL2—malignant glioma	0.000205	0.114	CrCbGaD
Melphalan—Hepatobiliary disease—Temozolomide—malignant glioma	0.000199	0.0052	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000197	0.0213	CbGpPWpGaD
Melphalan—Haemoglobin—Carmustine—malignant glioma	0.000196	0.00513	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—DOCK6—malignant glioma	0.000196	0.0212	CbGpPWpGaD
Melphalan—Haemorrhage—Carmustine—malignant glioma	0.000195	0.00511	CcSEcCtD
Melphalan—Connective tissue disorder—Carmustine—malignant glioma	0.000192	0.00502	CcSEcCtD
Melphalan—Haemoglobin—Temozolomide—malignant glioma	0.00019	0.00496	CcSEcCtD
Melphalan—Haemorrhage—Temozolomide—malignant glioma	0.000189	0.00494	CcSEcCtD
Melphalan—Hepatitis—Temozolomide—malignant glioma	0.000189	0.00494	CcSEcCtD
Melphalan—Urinary tract disorder—Temozolomide—malignant glioma	0.000186	0.00488	CcSEcCtD
Melphalan—Connective tissue disorder—Temozolomide—malignant glioma	0.000185	0.00485	CcSEcCtD
Melphalan—Urethral disorder—Temozolomide—malignant glioma	0.000185	0.00484	CcSEcCtD
Melphalan—SLC7A5—retina—malignant glioma	0.000181	0.15	CbGeAlD
Melphalan—Flushing—Carmustine—malignant glioma	0.000181	0.00474	CcSEcCtD
Melphalan—Flushing—Temozolomide—malignant glioma	0.000175	0.00458	CcSEcCtD
Melphalan—Arrhythmia—Carmustine—malignant glioma	0.000174	0.00456	CcSEcCtD
Melphalan—Alopecia—Carmustine—malignant glioma	0.000173	0.00451	CcSEcCtD
Melphalan—Immune system disorder—Temozolomide—malignant glioma	0.00017	0.00446	CcSEcCtD
Melphalan—Mediastinal disorder—Temozolomide—malignant glioma	0.00017	0.00445	CcSEcCtD
Melphalan—SLC7A5—telencephalon—malignant glioma	0.000167	0.138	CbGeAlD
Melphalan—Alopecia—Temozolomide—malignant glioma	0.000167	0.00436	CcSEcCtD
Melphalan—Ibuprofen—CXCL8—malignant glioma	0.000164	0.0916	CrCbGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000161	0.0174	CbGpPWpGaD
Melphalan—Anaemia—Carmustine—malignant glioma	0.000157	0.00411	CcSEcCtD
Melphalan—Leukopenia—Carmustine—malignant glioma	0.000152	0.00398	CcSEcCtD
Melphalan—Anaemia—Temozolomide—malignant glioma	0.000152	0.00397	CcSEcCtD
Melphalan—Convulsion—Carmustine—malignant glioma	0.000147	0.00385	CcSEcCtD
Melphalan—Leukopenia—Temozolomide—malignant glioma	0.000147	0.00385	CcSEcCtD
Melphalan—Chest pain—Carmustine—malignant glioma	0.000145	0.00379	CcSEcCtD
Melphalan—Myalgia—Carmustine—malignant glioma	0.000145	0.00379	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000143	0.0156	CbGpPWpGaD
Melphalan—Cough—Temozolomide—malignant glioma	0.000143	0.00375	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000143	0.0155	CbGpPWpGaD
Melphalan—Convulsion—Temozolomide—malignant glioma	0.000142	0.00372	CcSEcCtD
Melphalan—Myalgia—Temozolomide—malignant glioma	0.00014	0.00366	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000139	0.00363	CcSEcCtD
Melphalan—Oedema—Carmustine—malignant glioma	0.000139	0.00363	CcSEcCtD
Melphalan—Infection—Carmustine—malignant glioma	0.000138	0.00361	CcSEcCtD
Melphalan—Thrombocytopenia—Carmustine—malignant glioma	0.000136	0.00355	CcSEcCtD
Melphalan—Tachycardia—Carmustine—malignant glioma	0.000135	0.00354	CcSEcCtD
Melphalan—Oedema—Temozolomide—malignant glioma	0.000134	0.00351	CcSEcCtD
Melphalan—Anaphylactic shock—Temozolomide—malignant glioma	0.000134	0.00351	CcSEcCtD
Melphalan—Infection—Temozolomide—malignant glioma	0.000133	0.00348	CcSEcCtD
Melphalan—Anorexia—Carmustine—malignant glioma	0.000132	0.00346	CcSEcCtD
Melphalan—Thrombocytopenia—Temozolomide—malignant glioma	0.000131	0.00343	CcSEcCtD
Melphalan—SLC7A5—medulla oblongata—malignant glioma	0.000131	0.108	CbGeAlD
Melphalan—Skin disorder—Temozolomide—malignant glioma	0.00013	0.00341	CcSEcCtD
Melphalan—Hypotension—Carmustine—malignant glioma	0.00013	0.00339	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000128	0.0139	CbGpPWpGaD
Melphalan—Anorexia—Temozolomide—malignant glioma	0.000128	0.00334	CcSEcCtD
Melphalan—SLC22A3—embryo—malignant glioma	0.000127	0.105	CbGeAlD
Melphalan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000126	0.00331	CcSEcCtD
Melphalan—Paraesthesia—Carmustine—malignant glioma	0.000125	0.00326	CcSEcCtD
Melphalan—Dyspnoea—Carmustine—malignant glioma	0.000124	0.00324	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000122	0.0032	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CAV1—malignant glioma	0.000121	0.0131	CbGpPWpGaD
Melphalan—Decreased appetite—Carmustine—malignant glioma	0.000121	0.00316	CcSEcCtD
Melphalan—Paraesthesia—Temozolomide—malignant glioma	0.00012	0.00315	CcSEcCtD
Melphalan—SLC7A5—midbrain—malignant glioma	0.00012	0.0989	CbGeAlD
Melphalan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00012	0.00313	CcSEcCtD
Melphalan—Dyspnoea—Temozolomide—malignant glioma	0.000119	0.00313	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ATP1B2—malignant glioma	0.000119	0.0129	CbGpPWpGaD
Melphalan—Pain—Carmustine—malignant glioma	0.000119	0.0031	CcSEcCtD
Melphalan—Dyspepsia—Temozolomide—malignant glioma	0.000118	0.00309	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000118	0.0127	CbGpPWpGaD
Melphalan—SLC7A5—spinal cord—malignant glioma	0.000117	0.0965	CbGeAlD
Melphalan—Decreased appetite—Temozolomide—malignant glioma	0.000117	0.00305	CcSEcCtD
Melphalan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000116	0.00303	CcSEcCtD
Melphalan—Fatigue—Temozolomide—malignant glioma	0.000116	0.00302	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—F2—malignant glioma	0.000115	0.0125	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—FN1—malignant glioma	0.000115	0.0125	CbGpPWpGaD
Melphalan—Pain—Temozolomide—malignant glioma	0.000115	0.003	CcSEcCtD
Melphalan—Ibuprofen—PPARG—malignant glioma	0.000113	0.0633	CrCbGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000109	0.0119	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PTPN11—malignant glioma	0.000108	0.0117	CbGpPWpGaD
Melphalan—Urticaria—Temozolomide—malignant glioma	0.000106	0.00279	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000104	0.0113	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000103	0.0111	CbGpPWpGaD
Melphalan—Hypersensitivity—Carmustine—malignant glioma	0.000102	0.00267	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0001	0.0109	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOD—malignant glioma	9.99e-05	0.0108	CbGpPWpGaD
Melphalan—Asthenia—Carmustine—malignant glioma	9.95e-05	0.0026	CcSEcCtD
Melphalan—Hypersensitivity—Temozolomide—malignant glioma	9.87e-05	0.00258	CcSEcCtD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	9.86e-05	0.0107	CbGpPWpGaD
Melphalan—Asthenia—Temozolomide—malignant glioma	9.62e-05	0.00252	CcSEcCtD
Melphalan—Diarrhoea—Carmustine—malignant glioma	9.49e-05	0.00248	CcSEcCtD
Melphalan—Pruritus—Temozolomide—malignant glioma	9.48e-05	0.00248	CcSEcCtD
Melphalan—SLC7A5—central nervous system—malignant glioma	9.48e-05	0.0783	CbGeAlD
Melphalan—SLC7A5—cerebellum—malignant glioma	9.26e-05	0.0765	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	9.24e-05	0.01	CbGpPWpGaD
Melphalan—Diarrhoea—Temozolomide—malignant glioma	9.17e-05	0.0024	CcSEcCtD
Melphalan—Vomiting—Carmustine—malignant glioma	8.82e-05	0.00231	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	8.8e-05	0.00954	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ANGPT2—malignant glioma	8.75e-05	0.00949	CbGpPWpGaD
Melphalan—Rash—Carmustine—malignant glioma	8.74e-05	0.00229	CcSEcCtD
Melphalan—Dermatitis—Carmustine—malignant glioma	8.74e-05	0.00229	CcSEcCtD
Melphalan—Vomiting—Temozolomide—malignant glioma	8.52e-05	0.00223	CcSEcCtD
Melphalan—Rash—Temozolomide—malignant glioma	8.45e-05	0.00221	CcSEcCtD
Melphalan—Dermatitis—Temozolomide—malignant glioma	8.44e-05	0.00221	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—malignant glioma	8.43e-05	0.00914	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS1—malignant glioma	8.38e-05	0.0467	CrCbGaD
Melphalan—Nausea—Carmustine—malignant glioma	8.24e-05	0.00216	CcSEcCtD
Melphalan—Nausea—Temozolomide—malignant glioma	7.96e-05	0.00208	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—HIST1H3B—malignant glioma	7.57e-05	0.00822	CbGpPWpGaD
Melphalan—SLC7A5—brain—malignant glioma	7.52e-05	0.0621	CbGeAlD
Melphalan—SLC7A5—Hemostasis—MYB—malignant glioma	7.51e-05	0.00814	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—COX8A—malignant glioma	6.54e-05	0.0071	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—FTH1—malignant glioma	5.99e-05	0.00649	CbGpPWpGaD
Melphalan—SLC22A3—central nervous system—malignant glioma	5.88e-05	0.0486	CbGeAlD
Melphalan—SLC7A5—Hemostasis—H3F3A—malignant glioma	5.85e-05	0.00635	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—KRAS—malignant glioma	5.59e-05	0.00607	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—RTEL1—malignant glioma	5.34e-05	0.00579	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	5.23e-05	0.00568	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	5.14e-05	0.00557	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TFRC—malignant glioma	5.11e-05	0.00555	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOD—malignant glioma	5.09e-05	0.00552	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KNG1—malignant glioma	4.82e-05	0.00523	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—malignant glioma	4.79e-05	0.0267	CrCbGaD
Melphalan—SLC7A5—Hemostasis—IFNA2—malignant glioma	4.72e-05	0.00512	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	4.71e-05	0.00511	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.7e-05	0.00509	CbGpPWpGaD
Melphalan—SLC22A3—brain—malignant glioma	4.67e-05	0.0386	CbGeAlD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	4.48e-05	0.00486	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SOD1—malignant glioma	4.48e-05	0.00486	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.47e-05	0.00485	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PTK2—malignant glioma	4.11e-05	0.00446	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PDGFB—malignant glioma	3.45e-05	0.00375	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CAV1—malignant glioma	3.27e-05	0.00355	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F2—malignant glioma	3.12e-05	0.00338	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—FN1—malignant glioma	3.12e-05	0.00338	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—COX8A—malignant glioma	3.07e-05	0.00332	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CG—malignant glioma	2.98e-05	0.00323	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—EGF—malignant glioma	2.95e-05	0.0032	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PTPN11—malignant glioma	2.93e-05	0.00318	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT2—malignant glioma	2.73e-05	0.00296	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CD—malignant glioma	2.62e-05	0.00284	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ASMT—malignant glioma	2.61e-05	0.00283	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TFRC—malignant glioma	2.61e-05	0.00283	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BCAN—malignant glioma	2.45e-05	0.00266	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.39e-05	0.0026	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—RAF1—malignant glioma	2.34e-05	0.00254	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CB—malignant glioma	2.29e-05	0.00248	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.28e-05	0.00247	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IL2—malignant glioma	2.1e-05	0.00228	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.03e-05	0.0022	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—IDH2—malignant glioma	1.98e-05	0.00214	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2B6—malignant glioma	1.86e-05	0.00201	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—malignant glioma	1.78e-05	0.00193	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—IDH1—malignant glioma	1.7e-05	0.00184	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SPHK1—malignant glioma	1.64e-05	0.00178	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2C18—malignant glioma	1.61e-05	0.00175	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KRAS—malignant glioma	1.52e-05	0.00164	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CA—malignant glioma	1.39e-05	0.00151	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TP53—malignant glioma	1.35e-05	0.00146	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTT1—malignant glioma	1.3e-05	0.00141	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS1—malignant glioma	1.22e-05	0.00132	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—malignant glioma	1.14e-05	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BCHE—malignant glioma	1.13e-05	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC5A5—malignant glioma	1.12e-05	0.00122	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.03e-05	0.00112	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTP1—malignant glioma	9.03e-06	0.000979	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAT—malignant glioma	8.78e-06	0.000953	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NCOR1—malignant glioma	8.3e-06	0.0009	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAV1—malignant glioma	6.76e-06	0.000733	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CG—malignant glioma	6.16e-06	0.000668	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARG—malignant glioma	5.94e-06	0.000645	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CD—malignant glioma	5.41e-06	0.000587	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CB—malignant glioma	4.72e-06	0.000512	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—malignant glioma	4.68e-06	0.000507	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTEN—malignant glioma	4.08e-06	0.000442	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CA—malignant glioma	2.88e-06	0.000312	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—malignant glioma	2.35e-06	0.000255	CbGpPWpGaD
